Department of Clinical Sciences, Faculty of Health Sciences, The University of Bamenda, P. O Box, 818, Bamenda, Cameroon.
Bamenda Regional Hospital, Bamenda, Cameroon.
BMC Complement Med Ther. 2022 Dec 7;22(1):325. doi: 10.1186/s12906-022-03815-7.
Despite progress in haemodialysis and conventional medicine approaches, many patients still struggle to maintain an acceptable quality of life and turn to complementary and alternative medicine (CAM) to address their unmet needs.
This study aims to determine the prevalence, types, indications, and factors associated with CAM use by patients on maintenance haemodialysis (MHD) in Cameroon.
This was a multicentric cross-sectional study involving MHD patients in Cameroon from February 2019 to May 2019. We included all consenting participants on MHD for at least 3 months and excluded participants with cognitive and behavioral problems. Face-to-face interviews were conducted.
A total of 224 participants (145 males) with a mean age of 56.5 ± 14.2 years and a median haemodialysis vintage of 34.5 [IQR: 17.3-64.4] months were recruited. In all, 89.7% (n = 201) reported having used CAM before, while 71.6% (n = 144) were still using it. Biologically based therapies were the most popular (94%, n = 189), with herbal medicine (81.5%, n = 154) and Calabar chalk (52.4%, n = 99) being the most common. Physical well-being (57.2%), nausea (52%), and insomnia (42.7%) were the main indications for CAM use. Most respondents did not disclose their CAM use to their physicians (61.2%). Long haemodialysis vintage was associated with CAM use (AOR: 7.9; CI = 2.8-22.3; p < 0.001).
The use of CAM is common among Cameroon's haemodialysis population, with herbal medicines and Calabar chalk being the most frequent. The high symptom burden makes CAM attractive to them. Healthcare teams should be aware of these practices, initiate an open discussion, and appropriately advise patients about dangers, risks, and safety associated with their use.
The institutional review board of the University of Bamenda. Reference: 2019/0038H/UBa/IRB UPM/TNCPI/RMC/1.4.18.2.
尽管血液透析和传统医学方法取得了进展,但许多患者仍难以维持可接受的生活质量,因此转而采用补充和替代医学(CAM)来满足他们未满足的需求。
本研究旨在确定喀麦隆维持性血液透析(MHD)患者使用 CAM 的流行率、类型、适应证和相关因素。
这是一项多中心横断面研究,涉及 2019 年 2 月至 5 月期间喀麦隆的 MHD 患者。我们纳入了所有至少接受 3 个月 MHD 治疗且无认知和行为问题的同意参与者,并排除了这些参与者。采用面对面访谈的方式进行研究。
共招募了 224 名参与者(145 名男性),平均年龄为 56.5±14.2 岁,中位数血液透析龄为 34.5[IQR:17.3-64.4]个月。总共 89.7%(n=201)的患者报告曾使用过 CAM,而 71.6%(n=144)的患者仍在使用 CAM。基于生物学的疗法最受欢迎(94%,n=189),其中草药(81.5%,n=154)和卡拉巴尔白垩(52.4%,n=99)最为常见。身体不适(57.2%)、恶心(52%)和失眠(42.7%)是使用 CAM 的主要适应证。大多数受访者没有向医生透露他们的 CAM 使用情况(61.2%)。较长的血液透析龄与 CAM 使用相关(AOR:7.9;CI=2.8-22.3;p<0.001)。
CAM 在喀麦隆血液透析人群中很常见,草药和卡拉巴尔白垩最为常见。较高的症状负担使 CAM 对他们具有吸引力。医疗保健团队应该了解这些做法,进行开放讨论,并就其使用的危险、风险和安全性向患者提供适当的建议。
班吉大学伦理审查委员会。参考:2019/0038H/UBa/IRB UPM/TNCPI/RMC/1.4.18.2。